Ocugen, Inc.
Biotechnology company · Malvern, Pennsylvania, United States · Nasdaq: OCGN
Ocugen, Inc. is a biotechnology company headquartered in Malvern, Pennsylvania, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker OCGN. It has reported private securities offerings to the US SEC, most recently $395 sold in a notice filed in 2020.
Ocugen at a glance
What does Ocugen do?
Private fundraising reported to the SEC
12 Form D notices; the most recent reported $395 sold (2020).
Frequently asked questions about Ocugen
Where is Ocugen headquartered?
Ocugen, Inc. is headquartered in Malvern, Pennsylvania, United States.
What does Ocugen do?
Ocugen, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Ocugen a public company?
Yes. Ocugen, Inc. trades on Nasdaq under the ticker OCGN.
When was Ocugen founded?
The earliest incorporation on record for Ocugen, Inc. is in 2013, according to public company registers.
Similar companies
- Xylocor Therapeutics, Inc.Malvern, Pennsylvania, United States
- Shifa Biomedical CorpMalvern, Pennsylvania, United States
- Progenra IncMalvern, Pennsylvania, United States
- Lifesensors, Inc.Malvern, Pennsylvania, United States
- LifeSplice PharmaMalvern, Pennsylvania, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences